Resources

Novel Coronavirus (COVID-19) Patient Tracking Report—Wave 1

Wave 2 of this Tracking Report is now available here!

With the recent outbreak of the novel coronavirus (COVID-19) in the US, InCrowd wanted to understand how patients with chronic conditions and those who are immunocompromised have been impacted by the virus, and how they anticipate ways in which their lives and disease management will be affected moving forward.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.

Methodology:

  • Method: 9-minute MicroSurvey via InCrowd & Rare Patient Voice
  • Crowds: Patients with Mild to Severe Illness
  • Sample Size: n=152 (77 Mild to Moderate Patients, 75 Moderate to Severe Patients)
  • Fielding Period: March 25-26, 2020

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

Name(Required)
Consent
This field is for validation purposes and should be left unchanged.

Related Resources

Why Diversity Matters to Patients

Why Diversity Matters to Patients

How does a diverse patient audience feel about representation among their own physicians? Is the diversity outlook improving among healthcare professionals? Find out in our latest report from the 2023 Pharma Market Research Conference. We examined: Satisfaction with...

read more
ASH 2022 Real-Time Round-Up

ASH 2022 Real-Time Round-Up

The 2022 Annual Meeting of the American Society of Hematology (ASH) took place in person from December 10th to the 13th. InCrowd wanted to learn from those Hematologists and Hematology-Oncologists who attended these two objectives: Explore which condition had the most...

read more